Glenmark Pharma reports revenue growth of 22.5 per cent, EBITDA growth of 46.2 per cent YoY for Q1 FY 2023-24

Credit: newKerala.com- Published on August 12, 2023

👓 View full article:

You are here

› Business › Glenmark Pharma reports revenue growth of 22.5 per cent, EBITDA growth of 46.2 per cent YoY for Q1 FY 2023-24

You might like